Key facts
- Direava’s last known valuation is $11.3M (May 2025).
- It has raised $2.0M; the latest was Early Stage VC ($1.6M) in May 2025.
- Notable investors include SBI Investment, Nissay Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Direava
- ·The full record, as it builds
Funding rounds
No funding rounds for Direava are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Direava
Developer of an AI-assisted surgery system intended for building assistive technology that allows surgeons to identify important anatomical structures in real time during surgery. The company's platform automates surgery using AI to reduce complications during surgical procedures, enabling healthcare professionals to identify important anatomical structures in real time during surgery.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2023
- Website
- direava.com/
- Ownership
- Privately Held (backing)
Direava doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Direava shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Direava in its N-PORT filings yet. We sweep new filings monthly.